Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

6.2K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decline in physical function and baseline depressive symptoms are associated with worsening asthma outcomes in older adults: A 12-month prospective cohort study.

Respiratory investigation·2026
Same author

Validation of a Rule-Based Automated Method for RPE Cell Detection Using Adaptive Optics Transscleral Flood Illumination.

Translational vision science & technology·2026
Same author

RPE Abnormality Is a Potential Primary Cause for Retinal Degeneration in Mucopolysaccharidosis Type VI Patients and a Rat Model.

Investigative ophthalmology & visual science·2026
Same author

Genotype-Phenotype Correlations in RPGRIP1-Associated Retinal Dystrophy in a Nationwide Japanese Cohort.

American journal of ophthalmology·2026
Same author

Prospective natural history and clinical biomarkers of EYS-associated retinopathy in the KEYS study.

Scientific reports·2026
Same author

Earlier first-time memory clinic visits during the COVID-19 pandemic: A comparison of dementia severity and caregiver burden.

Journal of family medicine and primary care·2026

Related Experiment Video

Updated: Aug 18, 2025

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

7.8K

Optogenetic Therapy for Visual Restoration.

Daiki Sakai1,2,3, Hiroshi Tomita4, Akiko Maeda1,2

  • 1Department of Ophthalmology, Kobe City Eye Hospital, Kobe 650-0047, Japan.

International Journal of Molecular Sciences
|December 11, 2022
PubMed
Summary

Optogenetic therapy offers hope for vision restoration in retinal degenerative diseases. This review covers advancements in optogenetic tools and gene delivery for improved visual outcomes.

Keywords:
blindnesschannelrhodopsingene therapyopsinoptogeneticsretinaretinal degenerationretinal dystrophyretinitis pigmentosavisual restoration

More Related Videos

Selective Viral Transduction of Adult-born Olfactory Neurons for Chronic in vivo Optogenetic Stimulation
12:00

Selective Viral Transduction of Adult-born Olfactory Neurons for Chronic in vivo Optogenetic Stimulation

Published on: December 28, 2011

15.6K
Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
10:10

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

9.3K

Related Experiment Videos

Last Updated: Aug 18, 2025

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
12:56

Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro

Published on: December 19, 2017

7.8K
Selective Viral Transduction of Adult-born Olfactory Neurons for Chronic in vivo Optogenetic Stimulation
12:00

Selective Viral Transduction of Adult-born Olfactory Neurons for Chronic in vivo Optogenetic Stimulation

Published on: December 28, 2011

15.6K
Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research
10:10

Ultrahigh Resolution Mouse Optical Coherence Tomography to Aid Intraocular Injection in Retinal Gene Therapy Research

Published on: November 2, 2018

9.3K

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Gene Therapy

Background:

  • Optogenetics is a rapidly advancing neuroscience technique with significant potential for treating retinal degenerative diseases.
  • Clinical trials for optogenetic therapy are underway, offering hope for visual restoration in patients with late-stage degeneration.
  • Current gene therapy approaches for vision restoration are genotype-independent.

Purpose of the Study:

  • To provide an overview of optogenetic therapy advancements for visual restoration.
  • To focus on the available optogenetic tools and gene delivery methods.
  • To highlight the importance of selecting optimal tools and delivery systems for enhanced post-treatment vision.

Main Methods:

  • Review of current optogenetic tools, including engineered microbial and human opsins.
  • Analysis of various gene delivery systems for retinal cells.
  • Examination of clinical trial progress and technological successes.

Main Results:

  • Optogenetic tools have shown improved light and wavelength sensitivity through engineering.
  • Multiple options exist for target retinal cells, optogenetic tools, and gene delivery systems.
  • Technological advancements have led to successful development of various therapeutic elements.

Conclusions:

  • Optogenetic therapy is a promising approach for visual restoration in retinal degeneration.
  • Optimal selection of optogenetic tools and effective gene delivery are crucial for successful treatment.
  • Continued research and development in optogenetics offer significant hope for patients with vision loss.